Attached files
| file | filename |
|---|---|
| 8-K - 8-K - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | pacb-20140430x8k.htm |
| EX-99.1 - EX-99.1 - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | pacb-20140430ex991f0cf5e.htm |
| EX-99.2 - EX-99.2 - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | pacb-20140430ex992e0793c.htm |
Exhibit 99.3
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Condensed Consolidated Statements of Cash Flows
(Unaudited)
|
Three-Month Periods Ended March 31, |
|||||
|
(in thousands) |
2014 |
2013 |
|||
|
Cash flows from operating activities |
|||||
|
Net loss |
$ |
(18,886) |
$ |
(21,104) | |
|
Adjustments to reconcile net loss to net cash used in operating activities |
|||||
|
Depreciation |
1,221 | 1,493 | |||
|
Amortization of debt discount and financing costs |
182 | 89 | |||
|
Stock-based compensation |
2,270 | 2,746 | |||
|
Other |
— |
32 | |||
|
Changes in assets and liabilities |
|||||
|
Accounts receivable |
(637) | 813 | |||
|
Inventory |
1,749 | (607) | |||
|
Prepaid expenses and other assets |
(487) | 431 | |||
|
Accounts payable |
2,209 | 22 | |||
|
Accrued expenses and other current liabilities |
(2,119) | (779) | |||
|
Deferred service revenue |
258 | (423) | |||
|
Deferred contractual revenue |
(1,696) |
— |
|||
|
Deferred rent and other long-term liabilities |
(320) | (288) | |||
|
Net cash used in operating activities |
(16,256) | (17,575) | |||
|
Cash flows from investing activities |
|||||
|
Purchase of property and equipment |
(477) | (297) | |||
|
Purchase of investments |
(36,515) | (42,466) | |||
|
Maturities of investments |
45,190 | 37,180 | |||
|
Net cash provided by (used in) investing activities |
8,198 | (5,583) | |||
|
Cash flows from financing activities |
|||||
|
Proceeds from issuance of common stock from equity plans |
2,311 | 1,235 | |||
|
Proceeds from issuance of common stock from at-the-market equity offering, net of issuance costs |
20,646 | 8,655 | |||
|
Proceeds from issuance of Facility Agreement, net of issuance costs |
— |
19,766 | |||
|
Net cash provided by financing activities |
22,957 | 29,656 | |||
|
Net increase in cash and cash equivalents |
14,899 | 6,498 | |||
|
Cash and cash equivalents at beginning of period |
26,362 | 46,540 | |||
|
Cash and cash equivalents at end of period |
$ |
41,261 |
$ |
53,038 | |